Marlee Spangler
Senior Director of Investor Relations
Replay available
JBT Marel Corporation (NYSE: JBTM) Q4 2025 earnings conference call, held 2026-02-24. Replay captured from the company's public earnings webcast.

Senior Director of Investor Relations
Chief Executive Officer
President
Chief Financial Officer
Analyst, William Blair
Analyst, RW Baird
Analyst, CJS Securities
Analyst, Seaport Research
Welcome to JBT Morrell's earnings conference call for the fourth quarter and full year 2025. My name is Ellen, and I will be your conference operator today. As a reminder, today's call is being recorded. At this time, all lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question, please press star 1 on your telephone keypad. To withdraw your question, press star 1 again. I will now turn the call over to JBT Morrell's Senior Director of Investor Relations, Marlee Spangler, to begin today's conference. Thank you, Ellen. Good morning, everyone, and thank you for joining our year-end 2025 conference call. With me on the call is our Chief Executive Officer, Brian Deck, President Arne Sigurdsson, and Chief Financial Officer Matt Meister. In today's call, we will use forward-looking statements that are subject to the Safe Harbor language in yesterday's press release and 8 filing. JVT-MARL's periodic SEC filings also contain information regarding risk factors that may have an impact on our results. These documents are available on the IR website. Also, our discussion today includes references to certain non-GAAP measures. A reconciliation of these measures to the most comparable GAAP measure can be found on our IR website. With that, I'll turn the call over to Brian. Thanks, Marlene. Good morning. What a remarkable year 2025 has been as we completed our first year as JBT morale. I can proudly say we are meeting our commitments we made and are realizing the tremendous benefits of the JBT MRL combination. As a combined organization, we posted strong revenue growth and significant margin expansion. We capitalized on the anticipated recovery in protein demand with ...